Characterizing human abuse potential (HAP) liability
Characterizing human abuse potential liability can be dependent on many factors, including pharmacology, pharmacokinetics, and the intended population. We can help.
View More 
CenExel Acquires Apex Innovative Sciences
[et_pb_section fb_built=”1″ _builder_version=”4.12.0″ global_colors_info=”{}”][et_pb_row _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”] Salt Lake City, June 16, 2022 /GlobeNewswire/ — CenExel announces
View More CenExel Acquires iResearch
[et_pb_section fb_built=”1″ _builder_version=”3.22″ global_colors_info=”{}”][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″] Salt Lake City, May 3, 2022 /GlobeNewswire/ —
View More Preventing and Treating Bunions and Ingrown Toenails
As a CenExel Center of Excellence, JBR works with patients who are managing challenging conditions, such as bunions. As a medical researcher in pain management, I have worked with
View More CenExel Acquires Rocky Mountain Movement Disorders Center
[et_pb_section fb_built=”1″ _builder_version=”3.22″ global_colors_info=”{}”][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”]Salt Lake City, January 11, 2022 /GlobeNewswire/ — CenExel Clinical Research,
View More CenExel Acquires California Neuroscience Research
[et_pb_section fb_built=”1″ _builder_version=”3.22″ global_colors_info=”{}”][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”]Salt Lake City, January 10, 2022 /GlobeNewswire/ — CenExel Clinical Research,
View More CenExel Acquires Advanced Memory Research Institute
[et_pb_section admin_label=”section”] [et_pb_row admin_label=”row”] [et_pb_column type=”4_4″][et_pb_text admin_label=”Text”]Salt Lake City, August 19, 2021 /GlobeNewswire/ — CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of Advanced Memory Research Institute (“CenExel AMRI”),
View More Cali Biosciences Phase 2b Study on Post-Operative Pain
SAN DIEGO, August 12, 2021 /PRNewswire/ — Cali Biosciences Co., Ltd. (hereinafter referred to as “CaliBio”), a global biopharmaceutical company focused on the research and development of innovative drugs,
View More CenExel Acquires ForCare Clinical Research
Salt Lake City, August 4, 2021 /GlobeNewswire/ — CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of ForCare Clinical Research (“CenExel FCR”), a Tampa-based clinical research organization with Principal
View More Heron Therapeutics Publication on ZYNRELEF™
Heron Therapeutics Announces Publication Showing Reduction of Pain and Opioid Use Compared to Bupivacaine in Patients 65 and Older with ZYNRELEF™ SAN DIEGO, July 21, 2021 /PRNewswire/ — Heron
View More
